arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Ultragenyx Pharmaceutical Inc.

RARE Health Care Biotechnology: Pharmaceutical Preparations
$21.91
▼ -6.0% Today
as of Jun 7, 07:25 ET
Last 30 days -10.68% Apr 28 → Jun 05
$21.38 $22.84 $24.31 $25.78 $27.24 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$23.31
High
$23.41
Low
$21.74
Volume
$1M
Avg Vol
$2M
Mkt Cap
$2.3B
P/E (TTM)
Beta
52w High
$42.37
52w Low
$18.29
Div Yield
Shares Out
$98M

Overview

52-week range
$18
$42
15% of range
Avg surprise (last 2)
-10.3%
Avg reaction (last 2)
-4.5%
50% positive
Latest IV / EM
71%
EM ±9.8% · $23 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.25$-1.98$-1.71$-1.44$-1.17 Actual $-2.25Actual $-2.23Actual $-2.03Actual $-1.52Actual $-1.40Actual $-1.57Est $-1.54Actual $-1.17Actual $-1.81Actual $-1.84Est $-1.55 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-185M$-95M$-5M$85M$175M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-1.84 $-1.55 -18.7% -17.2% +0.8% earnings
Tue Sep 30, 2025Sep 2025 $-1.81 financials
Mon Jun 30, 2025Jun 2025 $-1.17 financials
Tue May 6, 2025Mar/2025 $-1.57 $-1.54 -1.9% -9.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.40 financials
Sun Jun 30, 2024Jun 2024 $-1.52 financials
Sun Mar 31, 2024Mar 2024 $-2.03 financials
Sat Sep 30, 2023Sep 2023 $-2.23 financials
Fri Jun 30, 2023Jun 2023 $-2.25 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$136M$160M$166M$139M$139M$147M
Cost of revenue
Gross profit
Operating income$-169M$-171M$-108M$-143M$-132M$-116M
Net income$-185M$-180M$-115M$-151M$-134M$-132M
EPS (diluted)$-1.84$-1.81$-1.17$-1.57$-1.40$-1.52

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$175M$421M$203M$176M$127M$174M$151M$481M
Inventory$55M$52M$52M$46M$46M$45M$43M$40M
Total current assets$657M$951M$643M$720M$699M$817M$800M$965M
Total assets$1.30B$1.53B$1.19B$1.31B$1.31B$1.50B$1.54B$1.62B
Long-term debt
Total liabilities$1.52B$1.60B$1.17B$1.15B$1.16B$1.24B$1.18B$1.19B
Total equity$-236M$-80M$9M$151M$144M$255M$347M$432M

Implied volatility — last 90 days

65%68%70%73%75% Jun 07 — IV 71% · EM ±9.8%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.